31 results on '"Roncoroni L."'
Search Results
2. Anorectal reconstruction by electrostimulated graciloplasty as part of abdominoperineal resection
3. 211MO Giredestrant (GDC-9545) vs physician choice of endocrine monotherapy (PCET) in patients (pts) with ER+, HER2– locally advanced/metastatic breast cancer (LA/mBC): Primary analysis of the phase II, randomised, open-label acelERA BC study
4. T.03.4 NOVEL STRATEGIES TO MONITOR CELIAC DISEASE
5. Alteration of Elastin, Collagen and their Cross-links in Abdominal Aortic Aneurysms
6. Giant abdominal stromal cell tumour diagnosed at endoscopic ultrasonography: is there a need for systematic use of endoscopic ultrasonography in submucosal gastric tumours?
7. AF.27 COVID-19 VACCINE: A SURVEY ON HESITANCY IN PATIENTS WITH CELIAC DISEASE
8. AF.26 EVALUATION OF GLUTEN IMMUNOGENIC PEPTIDES IN URINE OF CELIAC PATIENTS: A PROSPECTIVE TRIAL
9. OC.06.8 THE EMERGING ROLE OF TELEMEDICINE IN GASTROENTEROLOGY DURING THE COVID-19 PANDEMIC: A STUDY ON ITS FEASIBILITY AND PATIENTS’ TRUST
10. Delay in the diagnosis and outcome of colorectal cancer:a prospective study
11. T01.01.3 EVALUATION OF GLUTEN IMMUNOGENIC PEPTIDES IN URINE OF CELIAC PATIENTS: A PROSPECTIVE TRIAL
12. OC.06.6 UNRAVELLING REFRACTORY CELIAC DISEASE: A SINGLE CENTER EXPERIENCE
13. P.06.14 DIETARY ASSESSMENT IN CELIAC DISEASE PATIENTS UNDER A GLUTEN-FREE DIET AND FOLLOWING A LOW-FODMAP DIET
14. P.05.3 THE ROLE OF CAPSULE ENTEROSCOPY IN COELIAC DISEASE: RESULTS OF A PROSPECTIVE STUDY IN A TERTIARY REFERRAL CENTER
15. P.10.3 OXIDATIVE STRESS AS A BIOMARKER FOR MONITORING TREATED CELIAC DISEASE
16. P.10.13 SUCROSOMIAL IRON SUPPLEMENTATION IN ANAEMIC PATIENTS WITH CELIAC DISEASE NOT TOLERATING ORAL FERROUS SULPHATE: A PROSPECTIVE STUDY
17. P.10.19 EFFECTS OF A DIETARY APPROACH TO IRON DEFICIENCY IN WOMEN AFFECTED BY CELIAC DISEASE
18. OC.06.1 ROLE OF DIETARY FODMAPS (FERMENTABLE OLIGOSACCHARIDES, DISACCHARIDES, MONOSACCHARIDES, AND POLYOLS) INTAKE IN PERSISTENT GASTROINTESTINAL SYMPTOMS OF CELIAC PATIENTS AND CONTROLS
19. P.03.17: Effects of a Dietary Approach to Iron Deficiency in Women Affected by Celiac Disease
20. P.03.6: A Self Administered Blind Gluten Challenge Associated to a Dedicated Android/Ios Application (Test33™) to Diagnose Non-Celiac Gluten Sensitivity
21. P.06.7 GLIADIN EFFECT ON THE OXIDATIVE BALANCE AND DNA DAMAGE IN CACO-2 CELL LINE
22. OC.09.1 TRANSGLUTAMINASE 2 (TG2) MEDIATES THE CYTOTOXIC EFFECT OF RESVERATROL IN CHOLANGIOCARCINOMA (CC) CELL LINES
23. OC.06.5 ASSESSING THE RATE OF INCORRECT DIAGNOSIS OF CELIAC DISEASE: DATA FROM A TERTIARY REFERRAL CENTER
24. P.10.9 BILIARY OR “PANCREATIC” CHRONIC GASTRITIS?
25. P.02.8 A VISUAL-ANALOG SCALE-BASED DIETARY QUESTIONNAIRE TO ASSESS COMPLIANCE TO GLUTEN FREE DIET IN COELIAC PATIENTS
26. P.02.7 CELIAC DISEASE AND DRUG-BASED THERAPY: INDUSTRY OR PATIENT INTEREST?
27. P.02.4 DIETARY ASSESSMENT AND EVALUATION OF MYCOTOXIN EXPOSURE IN CELIAC DISEASE
28. OC.15.5 DOUBLE-BALLOON ENTEROSCOPY IN COMPLICATED CELIAC DISEASE: WHAT CAN WE ACHIEVE? THE EXPERIENCE OF TWO TERTIARY REFERRAL CENTERS
29. P.05.3 EVALUATION OF EXTRACELLULAR MATRIX PROTEINS AND DISPLACEMENT OF FIBROBLASTS FROM ENDOSCOPIC DUODENAL BIOPSIES OF CELIAC PATIENTS
30. P.68 TRANSGLUTAMINASE TYPE 2 INHIBITION REDUCES THE SEVERITY OF INFLAMMATION IN A RAT MODEL OF INFLAMMATORY BOWEL DISEASE
31. OC3.05.8 TRANSGLUTAMINASE EXPRESSION IN THE HEPATOBILIARY TRACT
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.